Figure 2From: Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinomaThe setup for the therapeutic dose measurement with a humanoid phantom. To measure the organ doses in the out-of-field region, two or three RPLGDs were inserted at the positions of interesting organs inside the humanoid phantom: the thyroid, small intestine, prostate/ovary, and rectum.Back to article page